Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Is Institutional Review Board (IRB) approval needed for an area to start HIV drug resistance and subtype surveillance?

April 26, 2017Approval area drug resistance institutional IRB needed review

0

Posted

Is Institutional Review Board (IRB) approval needed for an area to start HIV drug resistance and subtype surveillance?

1 Answer

0

Posted

Because HIV drug resistance and subtype surveillance has a federal non-research determination designating it a routine public health surveillance activity, neither CDC nor local IRB approval is required prior to implementation.